Accelerating Advanced Stem Cell Research
Scaling up Production to Reduce the Price
Advanced stem cell treatments holds the potential to transform health care as we know it. Despite this, there's a global shortage of stem cells produced in compliance with Good Manufacturing Practice (GMP) standards. To bridge this gap, Cellcolabs was established in 2021, aiming to meet the demand for high-quality, GMP-compliant stem cells in the healthcare sector.
Based on 25 years of experience
Cellcolabs is a biotech company specialising in Industrial GMP production of hhigh quality stem cells (Mesenchymal Stem Cells). The company is founded on the research conducted by Professor Katarina Le Blanc and co-founded by healthcare entrepreneur Per Båtelson, Maria Rankka and Norrsken. For two decades, Katarina's team at the Karolinska Institute has been dedicated to advancing stem cell research. Cellcolabs' mission is to leverage this expertise to provide high-quality stem cells on a larger scale.
What are MSCs?
Mesenchymal Stem Cells (MSCs) possess a multipotent differentiation capacity with the ability of self-renewal and generating into differentiated cells. Through their regenerative, immunomodulatory and anti-inflammatory effects, they could have the potential to improve or prevent many chronic diseases.
MSCs help restore old and damaged cells via their tissue regenerative properties. They also reduce inflammation by regulating the immune response to stable levels. As inflammation is believed to be the root cause of multiple diseases, the anti-inflammation property plays a vital role in the therapeutic use of MSC.
Research is conducted within the following fields, among many others.
- Graft versus host disease
- Cardiovascular diseases
- Aging frailty
- Alzheimer's disease
- Multiple sclerosis
- Arthritis (OA and RA)
- Orthopedic injuries
- Dystemic inflammatory diseases
- Acute kidney injury
- Parkinson's disease
- Wound healing
- Spinal cord injury
Located in Stockholm, Sweden, our production facility specialises in large-scale GMP production of bone marrow-derived MSCs for research, therapeutic applications. If interested in our MSCs for research use, please enquire below.
Advanced stem cell treatments holds the potential to transform healthcare as we know it. But we need your help to do it. Donate cells and be part of the research.
Looking for treatments?
Currently, we do not offer any stem cell treatments for commercial use. Our Mesenchymal Stem Cells (MSCs) are exclusively available to eligible participants enrolled in clinical trials conducted by our subsidiary or our partners’ clinical trials.